The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Adrenal-Tone
Adrenalinum, Avena, Ginkgo, Glycyrrhiza, Kali phos, Nat mur, Nux vomica, Phosphoricum ac, Pituitarum posterium, Sarsaparilla, Thyroidinum, Veratrum alb, Zinc met. · EPINEPHRINE 12 [hp_X]/59.1mL; AVENA SATIVA FLOWERING TOP 4 [hp_X]/59.1mL; GINKGO 4 [hp_X]/59.1mL; GLYCYRRHIZA GLABRA 4 [hp_X]/59.1mL; POTASSIUM PHOSPHATE, DIBASIC 12 [hp_X]/59.1mL; SODIUM CHLORIDE 12 [hp_X]/59.1mL; STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/59.1mL; PHOSPHORIC ACID 12 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; SARSAPARILLA 4 [hp_X]/59.1mL; THYROID, UNSPECIFIED 6 [hp_X]/59.1mL; VERATRUM ALBUM ROOT 12 [hp_X]/59.1mL; ZINC 12 [hp_X]/59.1mL · Liquid · Oral · Energetix Corporation
NDC 64578-0150-01 · 59.1 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Adrenalinum, Avena, Ginkgo, Glycyrrhiza, Kali phos, Nat mur, Nux vomica, Phosphoricum ac, Pituitarum posterium, Sarsaparilla, Thyroidinum, Veratrum alb, Zinc met. (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Energetix Corporation | EPINEPHRINE 12 [hp_X]/59.1mL; AVENA SATIVA FLOWERING TOP 4 [hp_X]/59.1mL; GINKGO 4 [hp_X]/59.1mL; GLYCYRRHIZA GLABRA 4 [hp_X]/59.1mL; POTASSIUM PHOSPHATE, DIBASIC 12 [hp_X]/59.1mL; SODIUM CHLORIDE 12 [hp_X]/59.1mL; STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/59.1mL; PHOSPHORIC ACID 12 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; SARSAPARILLA 4 [hp_X]/59.1mL; THYROID, UNSPECIFIED 6 [hp_X]/59.1mL; VERATRUM ALBUM ROOT 12 [hp_X]/59.1mL; ZINC 12 [hp_X]/59.1mL | Aug 26, 2026 | Sep 2, 2026 |
| Energetix Corporation | EPINEPHRINE 4 [hp_X]/59.1mL; AVENA SATIVA FLOWERING TOP 12 [hp_X]/59.1mL; GINKGO 4 [hp_X]/59.1mL; GLYCYRRHIZA GLABRA 4 [hp_X]/59.1mL; POTASSIUM PHOSPHATE, DIBASIC 12 [hp_X]/59.1mL; SODIUM CHLORIDE 12 [hp_X]/59.1mL; STRYCHNOS NUX-VOMICA SEED 4 [hp_X]/59.1mL; PHOSPHORIC ACID 12 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; SARSAPARILLA 12 [hp_X]/59.1mL; THYROID, UNSPECIFIED 6 [hp_X]/59.1mL; VERATRUM ALBUM ROOT 12 [hp_X]/59.1mL; ZINC 12 [hp_X]/59.1mL | Jul 22, 2026 | Aug 19, 2026 |
| Energetix Corporation | AVENA SATIVA FLOWERING TOP 4 [hp_X]/59.1mL; EPINEPHRINE 12 [hp_X]/59.1mL; GINKGO 4 [hp_X]/59.1mL; GLYCYRRHIZA GLABRA 4 [hp_X]/59.1mL; PHOSPHORIC ACID 12 [hp_X]/59.1mL; POTASSIUM PHOSPHATE, DIBASIC 12 [hp_X]/59.1mL; SARSAPARILLA 4 [hp_X]/59.1mL; SODIUM CHLORIDE 12 [hp_X]/59.1mL; STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/59.1mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL; THYROID, UNSPECIFIED 6 [hp_X]/59.1mL; VERATRUM ALBUM ROOT 12 [hp_X]/59.1mL; ZINC 12 [hp_X]/59.1mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Adrenal-Tone — NDC 64578-0150-01," retrieved September 3, 2026, https://drugdashboards.com/drug/64578015001.
Free to cite with attribution — see how the data is put together.